Table 1 Relationship between BICC1 mRNA expression and clinical features of PC in TCGA database
Characteristic | Low expression of BICC1 | High expression of BICC1 | P-value |
|---|---|---|---|
n | 89 | 89 | Â |
T stage, n (%) | Â | Â | 0.672 |
T1 | 5 (2.8%) | 2 (1.1%) | Â |
T2 | 12 (6.8%) | 12 (6.8%) | Â |
T3 | 69 (39.2%) | 73 (41.5%) | Â |
T4 | 2 (1.1%) | 1 (0.6%) | Â |
N stage, n (%) | Â | Â | 0.006 |
N0 | 33 (19.1%) | 17 (9.8%) | Â |
N1 | 51 (29.5%) | 72 (41.6%) | Â |
Pathologic stage, n (%) | Â | Â | 0.320 |
Stage I | 14 (8%) | 7 (4%) | Â |
Stage II | 69 (39.4%) | 77 (44%) | Â |
Stage III | 2 (1.1%) | 1 (0.6%) | Â |
Stage IV | 3 (1.7%) | 2 (1.1%) | Â |
Gender, n (%) | Â | Â | 0.175 |
Female | 35 (19.7%) | 45 (25.3%) | Â |
Male | 54 (30.3%) | 44 (24.7%) | Â |
Age, n (%) | Â | Â | 0.036 |
≤ 65 | 39 (21.9%) | 54 (30.3%) |  |
> 65 | 50 (28.1%) | 35 (19.7%) |  |
Histologic grade, n (%) | Â | Â | 0.369 |
G1 | 19 (10.8%) | 12 (6.8%) | Â |
G2 | 47 (26.7%) | 48 (27.3%) | Â |
G3 | 20 (11.4%) | 28 (15.9%) | Â |
G4 | 1 (0.6%) | 1 (0.6%) | Â |